nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—periosteum—periodontitis	0.0864	0.261	CbGeAlD
Irbesartan—JUN—endothelium—periodontitis	0.0318	0.0964	CbGeAlD
Irbesartan—JUN—mouth—periodontitis	0.0246	0.0744	CbGeAlD
Irbesartan—AGTR1—endothelium—periodontitis	0.024	0.0726	CbGeAlD
Irbesartan—JUN—neck—periodontitis	0.021	0.0636	CbGeAlD
Irbesartan—EDNRA—trigeminal ganglion—periodontitis	0.0199	0.0602	CbGeAlD
Irbesartan—JUN—trigeminal ganglion—periodontitis	0.0181	0.0549	CbGeAlD
Irbesartan—JUN—parotid gland—periodontitis	0.0171	0.0518	CbGeAlD
Irbesartan—AGTR1—neck—periodontitis	0.0158	0.0479	CbGeAlD
Irbesartan—JUN—connective tissue—periodontitis	0.0151	0.0456	CbGeAlD
Irbesartan—JUN—epithelium—periodontitis	0.0143	0.0433	CbGeAlD
Irbesartan—AGTR1—connective tissue—periodontitis	0.0113	0.0343	CbGeAlD
Irbesartan—AGTR1—epithelium—periodontitis	0.0108	0.0326	CbGeAlD
Irbesartan—PTGS1—endothelium—periodontitis	0.0105	0.0319	CbGeAlD
Irbesartan—PTGS1—connective tissue—periodontitis	0.00499	0.0151	CbGeAlD
Irbesartan—PTGS1—epithelium—periodontitis	0.00473	0.0143	CbGeAlD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—periodontitis	0.00103	0.00153	CbGpPWpGaD
Irbesartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00102	0.00153	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL3—periodontitis	0.00102	0.00152	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—LBP—periodontitis	0.00102	0.00152	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCR2—periodontitis	0.000996	0.00149	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—ADRB1—periodontitis	0.000991	0.00148	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL1B—periodontitis	0.000989	0.00148	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IFNG—periodontitis	0.000981	0.00146	CbGpPWpGaD
Irbesartan—JUN—IL6-mediated signaling events—IL6—periodontitis	0.000974	0.00146	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CXCL8—periodontitis	0.000968	0.00145	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—TGFB1—periodontitis	0.000962	0.00144	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00096	0.00143	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—GGT1—periodontitis	0.00095	0.00142	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—TGFB1—periodontitis	0.00094	0.0014	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—VIP—periodontitis	0.000939	0.0014	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—CXCL8—periodontitis	0.000933	0.00139	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—CCL2—periodontitis	0.000927	0.00138	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCR2—periodontitis	0.000922	0.00138	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—TNF—periodontitis	0.00092	0.00137	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—periodontitis	0.000912	0.00136	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—CXCL8—periodontitis	0.000912	0.00136	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—FCGR3A—periodontitis	0.000906	0.00135	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL1B—periodontitis	0.000895	0.00134	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—SLC52A3—periodontitis	0.00088	0.00131	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL1B—periodontitis	0.000875	0.00131	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—MMP2—periodontitis	0.000872	0.0013	CbGpPWpGaD
Irbesartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.000862	0.00129	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—PPARA—periodontitis	0.00086	0.00128	CbGpPWpGaD
Irbesartan—JUN—MAP kinase activation in TLR cascade—IL6—periodontitis	0.000847	0.00126	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCR2—periodontitis	0.000837	0.00125	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.000821	0.00123	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—MET—periodontitis	0.000818	0.00122	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—IL6—periodontitis	0.000812	0.00121	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—VIP—periodontitis	0.000812	0.00121	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL1A—periodontitis	0.000802	0.0012	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IFNG—periodontitis	0.000788	0.00118	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—TGFB1—periodontitis	0.000769	0.00115	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL3—periodontitis	0.000768	0.00115	CbGpPWpGaD
Irbesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—periodontitis	0.000767	0.00115	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—NOS2—periodontitis	0.00076	0.00114	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.000759	0.00113	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TNF—periodontitis	0.000759	0.00113	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—PTGS2—periodontitis	0.000756	0.00113	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—VIP—periodontitis	0.000737	0.0011	CbGpPWpGaD
Irbesartan—CYP1A2—Phase II conjugation—GGT1—periodontitis	0.00073	0.00109	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—CXCL8—periodontitis	0.000728	0.00109	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCR2—periodontitis	0.000723	0.00108	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CCR2—periodontitis	0.000717	0.00107	CbGpPWpGaD
Irbesartan—JUN—Immune System—CIITA—periodontitis	0.000714	0.00107	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—ADRB1—periodontitis	0.000714	0.00107	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—IL6—periodontitis	0.000708	0.00106	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—TNF—periodontitis	0.000705	0.00105	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL1B—periodontitis	0.000703	0.00105	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL1B—periodontitis	0.000699	0.00104	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—FCGR2A—periodontitis	0.000691	0.00103	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—FGF2—periodontitis	0.000686	0.00103	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TGFB1—periodontitis	0.00068	0.00102	CbGpPWpGaD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—periodontitis	0.00067	0.001	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.000664	0.000992	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TGFB1—periodontitis	0.00066	0.000985	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCR2—periodontitis	0.000657	0.000981	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCR2—periodontitis	0.000651	0.000972	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TNF—periodontitis	0.00065	0.00097	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000649	0.000969	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—ADRB1—periodontitis	0.000648	0.000968	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—TGFB1—periodontitis	0.000647	0.000966	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000646	0.000965	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.000644	0.000962	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL1B—periodontitis	0.00064	0.000957	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL1B—periodontitis	0.000637	0.000952	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CCL2—periodontitis	0.000625	0.000934	CbGpPWpGaD
Irbesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—periodontitis	0.000625	0.000933	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTSC—periodontitis	0.000624	0.000932	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL6—periodontitis	0.000624	0.000932	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—GGT1—periodontitis	0.000614	0.000917	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—IL6—periodontitis	0.000606	0.000906	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL3—periodontitis	0.000602	0.0009	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—periodontitis	0.000601	0.000897	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—IL1B—periodontitis	0.000601	0.000897	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CCR2—periodontitis	0.000599	0.000894	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.000595	0.000889	CbGpPWpGaD
Irbesartan—JUN—Immune System—LBP—periodontitis	0.000592	0.000884	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—IL6—periodontitis	0.00059	0.000881	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000583	0.00087	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL6—periodontitis	0.000579	0.000865	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CXCL8—periodontitis	0.000577	0.000862	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	0.000571	0.000852	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—IL6—periodontitis	0.000569	0.00085	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—IL6—periodontitis	0.000569	0.00085	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TGFB1—periodontitis	0.000566	0.000845	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCR2—periodontitis	0.000563	0.00084	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—ADRB1—periodontitis	0.00056	0.000837	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—IL6—periodontitis	0.00056	0.000836	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR2—periodontitis	0.000557	0.000831	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VIP—periodontitis	0.000555	0.000829	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—IL6—periodontitis	0.000537	0.000802	CbGpPWpGaD
Irbesartan—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	0.000534	0.000797	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.000531	0.000793	CbGpPWpGaD
Irbesartan—JUN—Immune System—FCGR3A—periodontitis	0.000527	0.000788	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL6—periodontitis	0.000524	0.000783	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ACP5—periodontitis	0.000519	0.000775	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL6—periodontitis	0.000512	0.000765	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL6—periodontitis	0.000512	0.000765	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCR2—periodontitis	0.000511	0.000763	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—TNF—periodontitis	0.00051	0.000762	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000509	0.000761	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—ADRB1—periodontitis	0.000509	0.00076	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TNF—periodontitis	0.000507	0.000757	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—GGT1—periodontitis	0.000504	0.000753	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD14—periodontitis	0.000502	0.000749	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—GGT1—periodontitis	0.0005	0.000746	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SLC52A3—periodontitis	0.000496	0.00074	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCR2—periodontitis	0.000495	0.000739	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CXCL8—periodontitis	0.000494	0.000738	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—MMP3—periodontitis	0.000493	0.000737	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000492	0.000735	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCL2—periodontitis	0.000491	0.000733	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—IL6—periodontitis	0.000483	0.000721	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TGFB1—periodontitis	0.000467	0.000697	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—TNF—periodontitis	0.000462	0.000691	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—IL6—periodontitis	0.000454	0.000678	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL3—periodontitis	0.00045	0.000672	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CXCL8—periodontitis	0.000436	0.000651	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—periodontitis	0.000436	0.000651	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VIP—periodontitis	0.000435	0.00065	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—GGT1—periodontitis	0.000427	0.000638	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000421	0.000629	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	0.000412	0.000616	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL6—periodontitis	0.000412	0.000615	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—AGER—periodontitis	0.000411	0.000614	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL6—periodontitis	0.000409	0.000611	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—IL6—periodontitis	0.000405	0.000604	CbGpPWpGaD
Irbesartan—JUN—Immune System—FCGR2A—periodontitis	0.000402	0.000601	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000393	0.000587	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCR2—periodontitis	0.000388	0.00058	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CXCL8—periodontitis	0.000388	0.000579	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—MMP3—periodontitis	0.000387	0.000578	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000386	0.000577	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	0.000385	0.000575	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.000385	0.000575	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR2—periodontitis	0.000385	0.000574	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ADRB1—periodontitis	0.000383	0.000572	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL6—periodontitis	0.000375	0.00056	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL6—periodontitis	0.000373	0.000557	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000365	0.000545	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CRP—periodontitis	0.000359	0.000536	CbGpPWpGaD
Irbesartan—JUN—Immune System—CCR2—periodontitis	0.000349	0.000521	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1RN—periodontitis	0.000347	0.000519	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR4—periodontitis	0.000344	0.000514	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	0.000337	0.000504	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GGT1—periodontitis	0.000329	0.000492	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VIP—periodontitis	0.000325	0.000486	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR2—periodontitis	0.000324	0.000484	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—periodontitis	0.000324	0.000484	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCL2—periodontitis	0.000321	0.000479	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SLC52A3—periodontitis	0.00032	0.000478	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NTRK1—periodontitis	0.000314	0.000468	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD79A—periodontitis	0.000305	0.000455	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—periodontitis	0.000305	0.000455	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR2—periodontitis	0.000302	0.000451	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ADRB1—periodontitis	0.0003	0.000449	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD14—periodontitis	0.000292	0.000437	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ACP5—periodontitis	0.000292	0.000436	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP3—periodontitis	0.000291	0.000435	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCR2—periodontitis	0.00029	0.000433	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GGT1—periodontitis	0.000289	0.000431	CbGpPWpGaD
Irbesartan—JUN—Immune System—VCAM1—periodontitis	0.000282	0.000421	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL8—periodontitis	0.000279	0.000417	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—FGF2—periodontitis	0.000267	0.000398	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC52A3—periodontitis	0.000263	0.000393	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000261	0.00039	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC52A3—periodontitis	0.000261	0.000389	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL8—periodontitis	0.000254	0.000379	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL2—periodontitis	0.000252	0.000376	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1A—periodontitis	0.00025	0.000373	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL18—periodontitis	0.000249	0.000373	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NTRK1—periodontitis	0.000246	0.000367	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—periodontitis	0.000245	0.000366	CbGpPWpGaD
Irbesartan—JUN—Immune System—AGER—periodontitis	0.00024	0.000358	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000236	0.000352	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP3—periodontitis	0.000229	0.000342	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR2—periodontitis	0.000225	0.000337	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADRB1—periodontitis	0.000224	0.000335	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC52A3—periodontitis	0.000223	0.000333	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL8—periodontitis	0.000219	0.000327	CbGpPWpGaD
Irbesartan—JUN—Immune System—CRP—periodontitis	0.000209	0.000312	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PPARA—periodontitis	0.000206	0.000308	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR4—periodontitis	0.0002	0.000299	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL8—periodontitis	0.000199	0.000297	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000192	0.000286	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL2—periodontitis	0.00019	0.000283	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ACP5—periodontitis	0.000189	0.000282	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NTRK1—periodontitis	0.000184	0.000275	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000172	0.000257	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—FGF2—periodontitis	0.000171	0.000256	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP3—periodontitis	0.000171	0.000255	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.00017	0.000254	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000169	0.000252	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000164	0.000245	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GGT1—periodontitis	0.000162	0.000243	CbGpPWpGaD
Irbesartan—JUN—Immune System—FGF2—periodontitis	0.000155	0.000232	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ACP5—periodontitis	0.000155	0.000231	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ACP5—periodontitis	0.000154	0.000229	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL8—periodontitis	0.00015	0.000224	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—periodontitis	0.000149	0.000222	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—periodontitis	0.000146	0.000218	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—periodontitis	0.000142	0.000213	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000137	0.000205	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—periodontitis	0.000136	0.000202	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FGF2—periodontitis	0.000134	0.000201	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—periodontitis	0.000134	0.000201	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ACP5—periodontitis	0.000131	0.000196	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—periodontitis	0.000131	0.000196	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—periodontitis	0.00013	0.000195	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL8—periodontitis	0.000118	0.000176	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000117	0.000175	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARA—periodontitis	0.000116	0.000174	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—periodontitis	0.000112	0.000167	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—periodontitis	0.000112	0.000167	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—periodontitis	0.000111	0.000166	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.00011	0.000164	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—periodontitis	0.000106	0.000159	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT1—periodontitis	0.000105	0.000157	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ACP5—periodontitis	0.000101	0.000151	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGF2—periodontitis	0.0001	0.00015	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	8.93e-05	0.000133	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—periodontitis	8.78e-05	0.000131	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—periodontitis	8.77e-05	0.000131	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT1—periodontitis	8.62e-05	0.000129	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT1—periodontitis	8.54e-05	0.000128	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—periodontitis	8.42e-05	0.000126	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—periodontitis	7.95e-05	0.000119	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—periodontitis	7.63e-05	0.000114	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	7.63e-05	0.000114	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—periodontitis	7.56e-05	0.000113	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARA—periodontitis	7.51e-05	0.000112	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT1—periodontitis	7.3e-05	0.000109	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—periodontitis	6.61e-05	9.87e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—periodontitis	6.55e-05	9.78e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARA—periodontitis	6.17e-05	9.21e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARA—periodontitis	6.11e-05	9.13e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT1—periodontitis	5.63e-05	8.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARA—periodontitis	5.22e-05	7.8e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—periodontitis	4.93e-05	7.37e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—periodontitis	4.88e-05	7.3e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARA—periodontitis	4.03e-05	6.02e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—periodontitis	4.01e-05	5.99e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—periodontitis	3.98e-05	5.94e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—periodontitis	3.4e-05	5.07e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—periodontitis	2.62e-05	3.92e-05	CbGpPWpGaD
